Advertisement
Research Article| Volume 12, ISSUE 3, P463-480, September 1992

Tay-Sachs Disease as a Model for Screening Inborn Errors

  • Miriam G. Blitzer
    Correspondence
    Address reprint requests to: Miriam G. Blitzer, PhD, Division of Human Genetics, University of Maryland School of Medicine, 655 W. Baltimore St, Room 11-037, Baltimore, MD 21201
    Affiliations
    From the Division of Human Genetics, Department of Pediatrics, and Biochemical Genetics Laboratory, University of Maryland School of Medicine, Baltimore
    Search for articles by this author
  • Geraldine A. McDowell
    Affiliations
    National Institute of Child Health and Human Development, Human Genetics Branch, Section on Biochemistry, National Institutes of Health, Bethesda, Maryland
    Search for articles by this author
DOI:https://doi.org/10.1016/S0272-2712(18)30500-6
Tay-Sachs Disease as a Model for Screening Inborn Errors
Previous ArticleLinkage Analysis and Predicting Genetic Disease
Next ArticleAlpha-Fetoprotein and Screening Markers of Congenital Disease
      This paper is only available as a PDF. To read, Please Download here.
      Without available treatments for most inborn errors of metabolism, prevention of disease by identification of couples at risk has been a goal of both geneticists and health care providers. This article, using Tay-Sachs disease as an example, focuses on how our understanding of genetic, biochemical, and molecular aspects of a metabolic disease can be applied to the development of a successful carrier screening program. Details of the biochemical assays used in the detection of Tay-Sachs disease carriers in addition to new molecular techniques that are being applied clinically are reviewed.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Andermann E.
        • Scriver C.R.
        • Wolf L.S.
        • et al.
        Genetic variants of Tay-Sachs disease: Tay-Sachs disease and Sandhoff’s disease in French Canadians, juvenile Tay-Sachs disease in Lebanese Canadians, and a Tay-Sachs screening program in the French Canadian population.
        Prog Clin Biol Res. 1977; 18: 161-188
        • Argov Z.
        • Navon R.
        Clinical and genetic variations in the syndrome of adult GM2 gangliosidosis resulting from hexosaminidase A deficiency.
        Ann Neurol. 1984; 16: 14-20
        • Arpaia E.
        • Dumbrille-Ross A.
        • Maler T.
        • et al.
        Identification of an altered splice site in Ashkenazi Tay-Sachs disease.
        Nature. 1988; 333: 85-86
        • Bayleran J.
        • Hechtman P.
        • Saray W.
        Synthesis of 4-methylumbelliferyl-βD-N acetylgluco-samine-6-sulfate and its use in classification of GM2 gangliosidosis genotypes.
        Clin Chim Acta. 1984; 143: 73-89
        • Boat T.F.
        • Welsh M.J.
        • Beaudet A.L.
        Cystic fibrosis.
        in: Scriver C.R. Beaudet A.L. Sly W.S. The Metabolic Basis of Inherited Disease. vol 2. McGraw-Hill, New York1989: 2649-2680
        • Clow C.L.
        • Scriver C.R.
        The adolescent copes with genetic screening: A study of Tay-Sachs screening among high-school students.
        Prog Clin Biol Res. 1977; 18: 381-394
        • Committee on Inborn Errors of Metabolism
        Genetic screening: Programs, principles, and research. National Academy of Sciences, Washington, DC1975
        • Conzelmann E.
        • Kytzia H.-J.
        • Navon R.
        • et al.
        Ganglioside GM2-N-acetyl-βD-galactosamin-idase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients of healthy probands with low hexosaminidase level.
        Am J Hum Genet. 1983; 35: 900-913
        • Culliton B.J.
        Genetic screening: NAS recommends proceeding with caution.
        Science. 1975; 189: 119-120
        • Erbzberger A.
        • Conzelmann E.
        • Sandhoff K.
        Assay of ganglioside GM2-N-acetyl-βD-galactosaminidase activity in human fibroblasts employing the natural activator protein-diagnosis of variant forms of GM2 gangliosidosis.
        Clin Chim Acta. 1980; 108: 361-368
        • Geiger B.
        • Arnon R.
        Chemical characterization and subunit structure of human N-acetyl-hexosaminidases A and B.
        Biochemistry. 1976; 15: 3484-3492
        • Grebner E.E.
        • Jackson L.G.
        Prenatal diagnosis of Tay-Sachs disease: Studies on the reliability of hexosaminidase levels in amniotic fluid.
        Am J Obstet Gynecol. 1979; 134: 574-580
        • Grebner E.E.
        • Jackson L.G.
        Prenatal diagnosis for Tay-Sachs disease using chorionic villus sampling.
        Prenat Diagn. 1985; 5: 313-320
        • Hechtman P.
        • Kaplan F.
        • Bayleran J.
        • et al.
        More than one mutant allele causes infantile Tay-Sachs disease in French-Canadians.
        Am J Hum Genet. 1990; 47: 815-822
        • Kaback M.M.
        Thermal fractionation of serum hexosaminidases: Applications to heterozygote detection and diagnosis of Tay-Sachs disease.
        Methods Enzymol. 1972; 28: 862
        • Kaback M.M.
        • Zeiger R.S.
        Heterozygote detectionin Tay-Sachs disease: A prototype community screening program for the prevention of recessive genetic disorders.
        in: Volk B.W. Aronson S.M. Sphingolipids, Sphingolipidoses, and Allied Disorders. Plenum Press, New York1972: 613-632
        • Kami A.
        • Navon R.
        • Sadeh M.
        Hexosaminidase A deficiency manifesting as spinal muscular atrophy of late onset.
        Ann Neurol. 1988; 24: 451-453
        • Klenk E.
        Bietrage aur chemie der lipoidosen.
        Neimann-Picksche krankheit und amaurotische idiotie. Z Physiol Chem. 1939; 262: 128
        • Korneluk R.G.
        • Mahura D.J.
        • Neotek Klavins M.H.
        • et al.
        Isolation of cDNA clones coding for the a-subunit of human ^-hexosaminidase.
        J Biol Chem. 1986; 261: 8407-8413
        • Lowden J.A.
        • Skomorowski M.A.
        • Henderson F.
        • et al.
        Automated assay of hexosaminidases in serum.
        Clin Chem. 1973; 19: 1345-1349
        • Mullis K.B.
        • Faloona F.A.
        Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction.
        Methods Enzymol. 1987; 155: 335-350
        • Myerowitz R.
        Splice junction mutation in some Ashkenazi Jews with Tay-Sachs disease:Evidence against a single defect within this ethnic group.
        Proc Natl Acad Sci USA. 1988; 85: 3955-3959
        • Myerowitz R.
        • Costigan F.C.
        The major defect in Ashkenazi Jews with Tay-Sachs disease is an insertion in the gene for the a-chain of βhexosaminidase.
        J Biol Chem. 1988; 263 (18,587-18): 589
        • Myerowitz R.
        • Hogikyan N.D.
        Different mutations in Ashkenazi Jewish and non-Jewish French Canadians with Tay-Sachs disease.
        Science. 1986; 232: 1646-1648
        • Myerowitz R.
        • Piekarz R.
        • Neufeld E.F.
        • et al.
        Human βhexosaminidase a-chain: Coding sequence and homology with the βchain.
        Proc Natl Acad Sci USA. 1985; 82: 7830-7834
        • Nagamine C.M.
        • Chan K.
        • Lau Y.-F.C.
        A PCR artifact: Generation of heteroduplexes.
        Am J Hum Genet. 1989; 45: 337-339
        • Navon R.
        • Proia R.L.
        Tay-Sachs disease in Moroccan Jews: Deletion of a phenylalanine in the a-subunit of βhexosaminidase.
        Am J Hum Genet. 1991; 48: 412-419
        • Navon R.
        • Proia R.L.
        The mutations in Ashkenazi Jews with adult GM2 gangliosidosis, the adult form of Tay-Sachs disease.
        Science. 1989; 243: 1471-1474
        • O’Brien J.S.
        • Ho M.W.
        • Okada S.
        • et al.
        Sphingolipidoses: Detection of heterozygotes and homozygotes.
        in: Volk B.W. Aronson S.M. Sphingolipids, Sphingolipidoses, and Allied Disorders. Plenum Press, New York1972: 581-597
        • O’Brien J.S.
        • Okoda S.
        • Chen A.
        • et al.
        Detection of heterozygotes and homozygotes by serum hexosaminidase assay.
        N Engl J Med. 1970; 283: 15-20
        • O’Brien J.S.
        • Okada S.G.
        • Fillerup D.L.
        • et al.
        Tay-Sachs disease: Prenatal diagnosis.
        Science. 1971; 172: 61-64
        • Okada S.
        • O’Brien J.S.
        Tay-Sachs disease: Generalized absence of a beta-D-N-acetylhexo-saminidase component.
        Science. 1969; 165: 698-700
        • Padeh B.
        • Shacher S.
        • Bat-Miriamketznelson M.
        • et al.
        Perspectives on screening and prevention of Tay-Sachs disease in Israel.
        Prog Clin Biol Res. 1977; 18: 47-54
        • Paw B.H.
        • Tieu P.T.
        • Kaback M.M.
        • et al.
        Frequency of three Hex A mutant alleles among Jewish and non-Jewish carriers identified in a Tay-Sachs screening program.
        Am J Hum Genet. 1990; 47: 698-705
        • Peterson G.M.
        • Rotter J.I.
        • Cantor R.M.
        • et al.
        The Tay-Sachs disease gene in North American Jewish populations: Geographic variations and origin.
        Am J Hum Genet. 1983; 35: 1258-1269

      36. Poenam L, Akli S, LaCorte J, et al: Molecular epidemiology of Tay-Sachs diseases in Europe. In Programs and Abstracts of the Fifth International Congress of Inborn Errors of Metabolism, Asilomer, CA, OC9.2, 1990

        • Proia R.L.
        • Soravia E.
        Organization of the gene encoding the human βhexosaminidase a-chain.
        J Biol Chem. 1987; 262: 5677-5681
        • Rosner F.
        Confidential Tay-Sachs carrier screening [letter].
        NY State J Med. 1989; (585 October)
        • Sachs B.
        On arrested cerebral development with special reference to its cortical pathology.
        J Nerv Ment Dis. 1887; 14: 541
        • Sachs B.
        A family form of idiocy, generally fatal, associated with early blindness.
        J Nerv Ment Dis. 1896; 21: 475
        • Saifer A.
        • Rosenthal A.L.
        Rapid test for the detection of Tay-Sachs disease heterozygotes and homozygotes by serum hexosaminidase assay.
        Clin Chim Acta. 1973; 43: 417-421
        • Saiki R.K.
        • Gelfand D.H.
        • Stoffel S.
        • et al.
        Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.
        Science. 1988; 239: 487-491
        • Sandhoff K.
        Auftrennung der sauger-N-acetyl-βD-hexosaminidase in multiple formen durch electrofokussierung.
        Hoppe Seylers Z Physiol Chem. 1968; 349: 1095-1098
        • Sandhoff K.
        • Christomanou H.
        Biochemistry and the genetics of gangliosides.
        Hum Genet. 1979; 50: 107-143
        • Sandhoff K.
        • Conselmann E.
        • Neufeld E.F.
        • et al.
        The GM2 gangliosidoses.
        in: Scriver C.R. Beaudet A.L. Sly W.S. The Metabolic Basis of Inherited Disease. vol. 2. McGraw-Hill, New York1989: 1807-1839
        • Shore S.
        • Myerowitz R.
        A gel electrophoretic assay for detecting the insertion defect in Ashkenazi Jewish carriers of Tay-Sachs disease.
        Anal Biochem. 1990; 186: 179-181
        • Southern E.M.
        Detection of specific sequences among DNA fragments separated by gel electrophoresis.
        J Mol Biol. 1975; 98: 503-517
        • Svennerholm L.
        The chemical structure of normal human brain and Tay-Sachs ganglio-side.
        Biochem Biophys Res Commun. 1962; 9: 345-441
        • Tay W.
        Symmetrical changes in the region of the yellow spot in each eye of an infant.
        Trans Ophthalmol Soc UK. 1881; 1: 155
        • Triggs-Raine B.L.
        • Feigenbaum A.S.J.
        • Natowicz M.
        • et al.
        Screening for carriers of Tay-Sachs disease among Ashkenazi Jews: A comparison of DNA-based and enzyme-based tests.
        N Engl J Med. 1990; 323: 6-12
        • Vecht J.
        • Zeigler M.
        • Segal M.
        • et al.
        Tay-Sachs disease among Moroccan Jews.
        Isr J Med Sci. 1983; 19: 67-69
        • Weatherall D.J.
        • Clegg J.B.
        • Higgs D.R.
        • et al.
        The hemoglobinopathies.
        in: Scriver C.R. Beaudet A.L. Sly W.S. The Metabolic Basis of Inherited Disease. vol 2. McGraw-Hill, New York1989: 2281-2339

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30500-6

      Copyright

      © 1992 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX